| 000 | 01696 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250513083439.0 | ||
| 264 | 0 | _c19960201 | |
| 008 | 199602s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWilliams, D L | |
| 245 | 0 | 0 |
_aPharmacology of L-754,142, a highly potent, orally active, nonpeptidyl endothelin antagonist. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cDec 1995 |
||
| 300 |
_a1518-26 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcetamides _xpharmacokinetics |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 | _aCHO Cells |
| 650 | 0 | 4 | _aCricetinae |
| 650 | 0 | 4 | _aEndothelin Receptor Antagonists |
| 650 | 0 | 4 |
_aEndothelins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aFerrets |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrolysis |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMuscle Contraction _xdrug effects |
| 650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xdrug effects |
| 650 | 0 | 4 |
_aPhosphatidylinositols _xmetabolism |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Endothelin _xmetabolism |
| 700 | 1 | _aMurphy, K L | |
| 700 | 1 | _aNolan, N A | |
| 700 | 1 | _aO'Brien, J A | |
| 700 | 1 | _aPettibone, D J | |
| 700 | 1 | _aKivlighn, S D | |
| 700 | 1 | _aKrause, S M | |
| 700 | 1 | _aLis, E V | |
| 700 | 1 | _aZingaro, G J | |
| 700 | 1 | _aGabel, R A | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 275 _gno. 3 _gp. 1518-26 |
|
| 999 |
_c8530230 _d8530230 |
||